What’s behind A2 Milk infant formula forecast cut?

A2 Milk warns of infant formula shortages

A2 Milk says it is facing shortages of China-label infant formula, which has already prompted the company to adjust its expectations. As a result, it has lowered its group sales and profit forecasts for fiscal 2026.

The issue is tied directly to supply availability in China: fewer saleable units means reduced revenue, and the company’s financial outlook shifts accordingly.

Why the shortage matters

Infant formula availability is a high-stakes category—both for household budgets and for parents who rely on specific products for their children. When supply tightens, demand doesn’t disappear, it reallocates, and brands can lose sales to substitutes or to competitors that have better availability.

This update also matters beyond A2 Milk because infant formula supply constraints can ripple through retail shelves and import channels. Companies often respond with revised distribution plans, regulatory engagement, or changes to sourcing, but specific remedies were not detailed here.

What we know—and what’s unclear

• A2 Milk explicitly linked its forecast reduction to infant formula supply challenges.
• The shortage was described as involving China-label infant formula.
• The report did not provide additional details on the root cause of the shortage (for example, manufacturing constraints, logistics delays, or regulatory steps).

For food news readers, the takeaway is straightforward: A2 Milk is recalibrating its financial outlook because formula supply is not keeping up with demand in its China-labeled line, and the company expects those constraints to continue impacting results into fiscal 2026.